(KDP) Keurig Dr Pepper - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US49271V1008
Stock: Coffee Pods, Soft Drinks, Juices, Energy Drinks, Hydration
Total Rating 32
Risk 74
Buy Signal -0.15
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.11% |
| Yield on Cost 5y | 3.25% |
| Yield CAGR 5y | 8.01% |
| Payout Consistency | 88.6% |
| Payout Ratio | 63.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 21.9% |
| Relative Tail Risk | -2.88% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.24 |
| Alpha | -12.18 |
| Character TTM | |
|---|---|
| Beta | 0.191 |
| Beta Downside | 0.160 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.99% |
| CAGR/Max DD | -0.14 |
Description: KDP Keurig Dr Pepper January 29, 2026
Keurig Dr Pepper Inc. (NASDAQ: KDP) manufactures, markets and distributes a broad portfolio of beverages and single-serve coffee systems across three operating segments-U.S. Refreshment Beverages, U.S. Coffee, and International-selling both owned brands (e.g., Dr Pepper, Snapple, Green Mountain, Bai) and licensed third-party brands (e.g., Starbucks, Dunkin’, McCafé) through retail, food-service and direct-to-consumer channels.
In FY 2023 the company generated $13.1 billion of revenue, with the Refreshment Beverages segment contributing roughly $7.0 billion, Coffee $3.6 billion and International $2.5 billion; net income was $1.2 billion and adjusted EPS $5.18, reflecting a 4 % YoY increase despite higher commodity costs for sugar and aluminum. The U.S. soft-drink market remains price-elastic, and KDP’s share of the carbonated segment is about 12 %-a figure that has been pressured by a consumer shift toward low-sugar and functional drinks, while premium coffee volumes are still expanding at ~5 % CAGR.
For a deeper quantitative dive, ValueRay’s platform offers granular segment forecasts and scenario analysis.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 1.58b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 0.93 > 1.0 |
| NWC/Revenue: -17.47% < 20% (prev -23.75%; Δ 6.27% < -1%) |
| CFO/TA 0.04 > 3% & CFO 2.13b > Net Income 1.58b |
| Net Debt (17.03b) to EBITDA (3.58b): 4.76 < 3 |
| Current Ratio: 0.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.36b) vs 12m ago 0.07% < -2% |
| Gross Margin: 54.76% > 18% (prev 0.56%; Δ 5420 % > 0.5%) |
| Asset Turnover: 30.14% > 50% (prev 28.73%; Δ 1.41% > 0%) |
| Interest Coverage Ratio: 4.29 > 6 (EBITDA TTM 3.58b / Interest Expense TTM 662.0m) |
Altman Z'' 0.55
| A: -0.05 (Total Current Assets 4.70b - Total Current Liabilities 7.53b) / Total Assets 54.60b |
| B: 0.10 (Retained Earnings 5.58b / Total Assets 54.60b) |
| C: 0.05 (EBIT TTM 2.84b / Avg Total Assets 53.66b) |
| D: 0.19 (Book Value of Equity 5.57b / Total Liabilities 29.28b) |
| Altman-Z'' Score: 0.55 = B |
Beneish M -2.98
| DSRI: 1.00 (Receivables 1.72b/1.62b, Revenue 16.17b/15.15b) |
| GMI: 1.02 (GM 54.76% / 55.69%) |
| AQI: 0.99 (AQ_t 0.84 / AQ_t-1 0.85) |
| SGI: 1.07 (Revenue 16.17b / 15.15b) |
| TATA: -0.01 (NI 1.58b - CFO 2.13b) / TA 54.60b) |
| Beneish M-Score: -2.98 (Cap -4..+1) = A |
What is the price of KDP shares?
As of February 07, 2026, the stock is trading at USD 28.41 with a total of 7,807,349 shares traded.
Over the past week, the price has changed by +3.53%, over one month by +3.91%, over three months by +8.67% and over the past year by -5.48%.
Over the past week, the price has changed by +3.53%, over one month by +3.91%, over three months by +8.67% and over the past year by -5.48%.
Is KDP a buy, sell or hold?
Keurig Dr Pepper has received a consensus analysts rating of 4.10.
Therefore, it is recommended to buy KDP.
- StrongBuy: 9
- Buy: 5
- Hold: 7
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the KDP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 34.4 | 21.2% |
| Analysts Target Price | 34.4 | 21.2% |
| ValueRay Target Price | 29 | 2.1% |
KDP Fundamental Data Overview February 05, 2026
P/E Trailing = 24.1121
P/E Forward = 12.7877
P/S = 2.3494
P/B = 1.5005
P/EG = 0.6874
Revenue TTM = 16.17b USD
EBIT TTM = 2.84b USD
EBITDA TTM = 3.58b USD
Long Term Debt = 13.53b USD (from longTermDebt, last quarter)
Short Term Debt = 2.57b USD (from shortTermDebt, last quarter)
Debt = 17.55b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 17.03b USD (from netDebt column, last quarter)
Enterprise Value = 55.03b USD (38.00b + Debt 17.55b - CCE 516.0m)
Interest Coverage Ratio = 4.29 (Ebit TTM 2.84b / Interest Expense TTM 662.0m)
EV/FCF = 34.12x (Enterprise Value 55.03b / FCF TTM 1.61b)
FCF Yield = 2.93% (FCF TTM 1.61b / Enterprise Value 55.03b)
FCF Margin = 9.97% (FCF TTM 1.61b / Revenue TTM 16.17b)
Net Margin = 9.78% (Net Income TTM 1.58b / Revenue TTM 16.17b)
Gross Margin = 54.76% ((Revenue TTM 16.17b - Cost of Revenue TTM 7.32b) / Revenue TTM)
Gross Margin QoQ = 54.34% (prev 54.17%)
Tobins Q-Ratio = 1.01 (Enterprise Value 55.03b / Total Assets 54.60b)
Interest Expense / Debt = 1.07% (Interest Expense 188.0m / Debt 17.55b)
Taxrate = 22.30% (190.0m / 852.0m)
NOPAT = 2.21b (EBIT 2.84b * (1 - 22.30%))
Current Ratio = 0.62 (Total Current Assets 4.70b / Total Current Liabilities 7.53b)
Debt / Equity = 0.69 (Debt 17.55b / totalStockholderEquity, last quarter 25.32b)
Debt / EBITDA = 4.76 (Net Debt 17.03b / EBITDA 3.58b)
Debt / FCF = 10.56 (Net Debt 17.03b / FCF TTM 1.61b)
Total Stockholder Equity = 24.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.95% (Net Income 1.58b / Total Assets 54.60b)
RoE = 6.39% (Net Income TTM 1.58b / Total Stockholder Equity 24.75b)
RoCE = 7.42% (EBIT 2.84b / Capital Employed (Equity 24.75b + L.T.Debt 13.53b))
RoIC = 5.44% (NOPAT 2.21b / Invested Capital 40.55b)
WACC = 4.79% (E(38.00b)/V(55.55b) * Re(6.62%) + D(17.55b)/V(55.55b) * Rd(1.07%) * (1-Tc(0.22)))
Discount Rate = 6.62% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -1.38%
[DCF Debug] Terminal Value 83.86% ; FCFF base≈1.39b ; Y1≈1.12b ; Y5≈770.7m
Fair Price DCF = 4.88 (EV 23.67b - Net Debt 17.03b = Equity 6.63b / Shares 1.36b; r=5.90% [WACC]; 5y FCF grow -23.32% → 2.90% )
EPS Correlation: -9.55 | EPS CAGR: -43.04% | SUE: -4.0 | # QB: 0
Revenue Correlation: 76.43 | Revenue CAGR: 6.58% | SUE: 3.40 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.43 | Chg30d=-0.000 | Revisions Net=-1 | Analysts=10
EPS next Year (2026-12-31): EPS=2.17 | Chg30d=-0.001 | Revisions Net=+0 | Growth EPS=+6.3% | Growth Revenue=+4.8%
P/E Forward = 12.7877
P/S = 2.3494
P/B = 1.5005
P/EG = 0.6874
Revenue TTM = 16.17b USD
EBIT TTM = 2.84b USD
EBITDA TTM = 3.58b USD
Long Term Debt = 13.53b USD (from longTermDebt, last quarter)
Short Term Debt = 2.57b USD (from shortTermDebt, last quarter)
Debt = 17.55b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 17.03b USD (from netDebt column, last quarter)
Enterprise Value = 55.03b USD (38.00b + Debt 17.55b - CCE 516.0m)
Interest Coverage Ratio = 4.29 (Ebit TTM 2.84b / Interest Expense TTM 662.0m)
EV/FCF = 34.12x (Enterprise Value 55.03b / FCF TTM 1.61b)
FCF Yield = 2.93% (FCF TTM 1.61b / Enterprise Value 55.03b)
FCF Margin = 9.97% (FCF TTM 1.61b / Revenue TTM 16.17b)
Net Margin = 9.78% (Net Income TTM 1.58b / Revenue TTM 16.17b)
Gross Margin = 54.76% ((Revenue TTM 16.17b - Cost of Revenue TTM 7.32b) / Revenue TTM)
Gross Margin QoQ = 54.34% (prev 54.17%)
Tobins Q-Ratio = 1.01 (Enterprise Value 55.03b / Total Assets 54.60b)
Interest Expense / Debt = 1.07% (Interest Expense 188.0m / Debt 17.55b)
Taxrate = 22.30% (190.0m / 852.0m)
NOPAT = 2.21b (EBIT 2.84b * (1 - 22.30%))
Current Ratio = 0.62 (Total Current Assets 4.70b / Total Current Liabilities 7.53b)
Debt / Equity = 0.69 (Debt 17.55b / totalStockholderEquity, last quarter 25.32b)
Debt / EBITDA = 4.76 (Net Debt 17.03b / EBITDA 3.58b)
Debt / FCF = 10.56 (Net Debt 17.03b / FCF TTM 1.61b)
Total Stockholder Equity = 24.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.95% (Net Income 1.58b / Total Assets 54.60b)
RoE = 6.39% (Net Income TTM 1.58b / Total Stockholder Equity 24.75b)
RoCE = 7.42% (EBIT 2.84b / Capital Employed (Equity 24.75b + L.T.Debt 13.53b))
RoIC = 5.44% (NOPAT 2.21b / Invested Capital 40.55b)
WACC = 4.79% (E(38.00b)/V(55.55b) * Re(6.62%) + D(17.55b)/V(55.55b) * Rd(1.07%) * (1-Tc(0.22)))
Discount Rate = 6.62% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -1.38%
[DCF Debug] Terminal Value 83.86% ; FCFF base≈1.39b ; Y1≈1.12b ; Y5≈770.7m
Fair Price DCF = 4.88 (EV 23.67b - Net Debt 17.03b = Equity 6.63b / Shares 1.36b; r=5.90% [WACC]; 5y FCF grow -23.32% → 2.90% )
EPS Correlation: -9.55 | EPS CAGR: -43.04% | SUE: -4.0 | # QB: 0
Revenue Correlation: 76.43 | Revenue CAGR: 6.58% | SUE: 3.40 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.43 | Chg30d=-0.000 | Revisions Net=-1 | Analysts=10
EPS next Year (2026-12-31): EPS=2.17 | Chg30d=-0.001 | Revisions Net=+0 | Growth EPS=+6.3% | Growth Revenue=+4.8%